Výsledky vyhledávání - "Eszter, Gorka"

Efficacy of Vemurafenib Treatment in 43 Metastatic Melanoma Patients with BRAF Mutation. Single-Institute Retrospective Analysis, Early Real-Life Survival Data

Autor: András Gézsi, Gabriella Liszkay, Tímea Balatoni, Eszter Gorka, Krisztina Melegh, Peter Kovacs, Kata Czirbesz, Gitta Pánczél

Publikováno v: Pathology & Oncology Research. 25:45-50

BRAF inhibitor vemurafenib achieved improved overall survival over chemotherapy and have been approved by the FDA and EMA for the treatment of BRAF-mutated metastatic melanoma. The aim of our retrospective analysis was to determine the efficacy and s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b7a5f4c608fb3d2413c30d70787f168
https://doi.org/10.1007/s12253-017-0324-1

Zobrazit plný text záznamu

Our experiences with the combination therapy of vemurafenib and cobimetinib in metastatic melanoma patient

Autor: Eszter Gorka, Kata Czirbesz, András Gézsi, Gabriella Liszkay

Publikováno v: Bőrgyógyászati és Venerológiai Szemle. 93:168-171

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ec255be9c06e4eeff22b561b61aac16f
https://doi.org/10.7188/bvsz.2017.93.4.5

Zobrazit plný text záznamu

Dabrafenib Therapy in 30 Patients with Melanoma Metastatic to the Brain: a Single-centre Controlled Retrospective Study in Hungary

Autor: Eszter Gorka, Imre Fedorcsák, Gabriella Liszkay, Kata Czirbesz, Dániel Fabó, András Gézsi

Publikováno v: Pathology oncology research : POR. 24(2)

Dabrafenib is a potent BRAF inhibitor, which showed intracranial tumor activity. The purpose of our retrospective analysis was to evaluate the efficacy of dabrafenib for patients with melanoma brain metastasis (BM). We studied 30 BRAF mutant melanoma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c326bad215d294801e4666bbb0174c4
https://pubmed.ncbi.nlm.nih.gov/28567600

Zobrazit plný text záznamu

Distance from Primary Tumor Is the Strongest Predictor for Early Onset of Brain Metastases in Melanoma

Autor: Eszter, Gorka, Dániel, Fabó, András, Gézsi, Kata, Czirbesz, Gabriella, Liszkay

Publikováno v: Anticancer research. 36(6)

The frequency of brain metastasis (BM) is up to 45-50% in patients with advanced melanoma. Our aim was to identify the risk factors for the early occurrence of BM.A total of 333 patients with BM were identified from our database of 2,972 patients wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f57e3931868b48f24879fbec2a4559d2
https://pubmed.ncbi.nlm.nih.gov/27272828

Zobrazit plný text záznamu

[Psychological aspects of immunotherapies in the treatment of malignant melanoma]

Autor: Péter, Kovács, Gitta, Pánczél, Krisztina, Melegh, Tímea, Balatoni, Edit, Pörneczy, Lenke, Lõrincz, Kata, Czirbesz, Eszter, Gorka, Gabriella, Liszkay

Publikováno v: Magyar onkologia. 60(1)

Psychological problems may arise in connection with oncomedical treatments in three ways: 1. acute and/or 2. chronic ways, as well as 3. co-morbid psychiatric diseases that already exist must also be taken into account. Immunotherapies have the most

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ff43bdff27be098c934635324cf8541a
https://pubmed.ncbi.nlm.nih.gov/26934347

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání